Ashok Joshi And Sons Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 1.00 M
as on 07-07-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.59 Cr
as on 07-07-2024
- Revenue 39.77%
(FY 2019)
- Profit 145.08%
(FY 2019)
- Ebitda 298.96%
(FY 2019)
- Net Worth 22.15%
(FY 2019)
- Total Assets 61.41%
(FY 2019)
About Ashok Joshi And Sons Meditech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.59 Cr.
Jasoda Joshi, Ramesh Joshi, Manish Joshi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51909RJ2017PTC058590
- Company No.
058590
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2017
- Date of AGM
29 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Pali, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ashok Joshi And Sons Meditech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sajjan Joshi  | Managing Director | 19-Jul-2017 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jasoda Joshi | Director | 22-Jul-2017 | Current |
| Ramesh Joshi | Director | 22-Jul-2017 | Current |
| Manish Joshi | Director | 19-Jul-2017 | Current |
| Seema Joshi | Director | 22-Jul-2017 | Current |
Financial Performance of Ashok Joshi And Sons Meditech.
Ashok Joshi And Sons Meditech Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 39.77% increase. The company also saw a substantial improvement in profitability, with a 145.08% increase in profit. The company's net worth Soared by an impressive increase of 22.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ashok Joshi And Sons Meditech?
In 2019, Ashok Joshi And Sons Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Apr 2020 | ₹3.38 M | Open |
City Union Bank Limited Creation Date: 16 Dec 2017 | ₹2.25 Cr | Open |
How Many Employees Work at Ashok Joshi And Sons Meditech?
Ashok Joshi And Sons Meditech has a workforce of 11 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ashok Joshi And Sons Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ashok Joshi And Sons Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
